000 01399 a2200409 4500
005 20250514005259.0
264 0 _c20010920
008 200109s 0 0 eng d
022 _a0269-9370
024 7 _a10.1097/00002030-200107270-00005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBirk, M
245 0 0 _aKinetics of HIV-1 RNA and resistance-associated mutations after cessation of antiretroviral combination therapy.
_h[electronic resource]
260 _bAIDS (London, England)
_cJul 2001
300 _a1359-68 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAnti-HIV Agents
_xadverse effects
650 0 4 _aDrug Resistance, Microbial
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aGenes, pol
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHIV-1
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMutation
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aRNA, Viral
_xdrug effects
650 0 4 _aSequence Analysis, RNA
650 0 4 _aViral Load
700 1 _aSvedhem, V
700 1 _aSönnerborg, A
773 0 _tAIDS (London, England)
_gvol. 15
_gno. 11
_gp. 1359-68
856 4 0 _uhttps://doi.org/10.1097/00002030-200107270-00005
_zAvailable from publisher's website
999 _c11430060
_d11430060